Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
295 Novel T-cell immunotherapeutics enable the selective generation of more potently cytotoxic CD19 chimeric antigen receptor T-cells (CAR-T cells) from CMV-specific cytotoxic T-cells
Compose a Response to This Article
Other responses
No responses have been published for this article.
